{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:35:17Z","timestamp":1772429717787,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"DOI":"10.7759\/cureus.104509","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T04:09:55Z","timestamp":1772424595000},"source":"Crossref","is-referenced-by-count":0,"title":["Intensive Care Management of Anti-Mi2\u2013Positive Dermatomyositis: Lupus Overlap Syndrome"],"prefix":"10.7759","author":[{"given":"Maria Dioselina","family":"Ruiz Barrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Alaciel","family":"Galvan Merlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Omar","family":"Castro Meza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafne Thamara","family":"Ayala Davila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janeet","family":"Gardu\u00f1o Becerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.19.2367","article-title":"Intravenous immunoglobulin in autoimmune neuromuscular diseases","volume":"291","author":"Dalakas MC","year":"2004","unstructured":"Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. 2004, 291:2367-2375. 10.1001\/jama.291.19.2367","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg IE","year":"2016","unstructured":"Lundberg IE, Miller FW, Tj\u00e4rnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016, 280:39-51. 10.1111\/joim.12524","journal-title":"J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge Z","year":"2016","unstructured":"Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016, 280:8-23. 10.1111\/joim.12451","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4032-3","article-title":"The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders","volume":"37","author":"Gofrit SG","year":"2018","unstructured":"Gofrit SG, Yonath H, Lidar M, Shoenfeld Y, Kivity S. The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders. Clin Rheumatol. 2018, 37:1257-1263. 10.1007\/s10067-018-4032-3","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.01.56","article-title":"Polymyositis\/dermatomyositis is a potential risk factor for acute respiratory failure: a pulmonary heart disease","volume":"8","author":"Syue SH","year":"2020","unstructured":"Syue SH, Chang YH, Shih PJ, Lin CL, Yeh JJ, Kao CH. Polymyositis\/dermatomyositis is a potential risk factor for acute respiratory failure: a pulmonary heart disease. Ann Transl Med. 2020, 8:202. 10.21037\/atm.2020.01.56","journal-title":"Ann Transl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216375","article-title":"Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients","volume":"80","author":"Ogawa-Momohara M","year":"2021","unstructured":"Ogawa-Momohara M, Muro Y, Akiyama M. Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients. Ann Rheum Dis. 2021, 80:e147. 10.1136\/annrheumdis-2019-216375","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"83","author":"Dank\u00f3 K","year":"2004","unstructured":"Dank\u00f3 K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore). 2004, 83:35-42. 10.1097\/01.md.0000109755.65914.5e","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk JE","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, et al.. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004, 14:337-245. 10.1016\/j.nmd.2004.02.006","journal-title":"Neuromuscul Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211032457","article-title":"Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders","volume":"13","author":"Kuwana M","year":"2021","unstructured":"Kuwana M, Gil-Vila A, Selva-O'Callaghan A. Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis. 2021, 13:10.1177\/1759720X211032457","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2014 evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith L","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA, et al.. Guidelines on the use of therapeutic apheresis in clinical practice \u2014 evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue. J Clin Apher. 2023, 38:77-278. 10.1002\/jca.22043","journal-title":"J Clin Apher"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21470","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2014 evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz J","year":"2016","unstructured":"Schwartz J, Padmanabhan A, Aqui N, et al.. Guidelines on the use of therapeutic apheresis in clinical practice \u2014 evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue. J Clin Apher. 2016, 31:149-162. 10.1002\/jca.21470","journal-title":"J Clin Apher"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000013176","article-title":"Dermatomyositis: muscle pathology according to antibody subtypes","volume":"98","author":"Tanboon J","year":"2022","unstructured":"Tanboon J, Inoue M, Saito Y, et al.. Dermatomyositis: muscle pathology according to antibody subtypes. Neurology. 2022, 98:e739-e749. 10.1212\/WNL.0000000000013176","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis","volume":"51","author":"Findlay AR","year":"2015","unstructured":"Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve. 2015, 51:638-656. 10.1002\/mus.24566","journal-title":"Muscle Nerve"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20088","article-title":"Monocyte\/macrophage differentiation in dermatomyositis and polymyositis","volume":"30","author":"Rostasy KM","year":"2004","unstructured":"Rostasy KM, Piepkorn M, Goebel HH, Menck S, Hanefeld F, Schulz-Schaeffer WJ. Monocyte\/macrophage differentiation in dermatomyositis and polymyositis. Muscle Nerve. 2004, 30:225-230. 10.1002\/mus.20088","journal-title":"Muscle Nerve"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05119.x","article-title":"Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis","volume":"1184","author":"Mammen AL","year":"2010","unstructured":"Mammen AL. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci. 2010, 1184:134-153. 10.1111\/j.1749-6632.2009.05119.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh M","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol. 2017, 52:1-19. 10.1007\/s12016-015-8510-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-0114","article-title":"A rare case of anti-Mi-2 antibody-positive dermatomyositis associated with gastrointestinal stromal tumor","volume":"51","author":"Akpoigbe O","year":"2024","unstructured":"Akpoigbe O, Anim-Koranteng C, Tasmin R, Sammut A. A rare case of anti-Mi-2 antibody-positive dermatomyositis associated with gastrointestinal stromal tumor. J Rheumatol. 2024, 51:944-945. 10.3899\/jrheum.2024-0114","journal-title":"J Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00325-7","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg IE","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, et al.. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021, 7:87. 10.1038\/s41572-021-00325-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas MC","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015, 372:1734-1747. 10.1056\/NEJMra1402225","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/461254-intensive-care-management-of-anti-mi2-positive-dermatomyositis-lupus-overlap-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T04:09:57Z","timestamp":1772424597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/461254-intensive-care-management-of-anti-mi2-positive-dermatomyositis-lupus-overlap-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.104509","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}